Talk to Robyn

(866) 682 9815

All regions

Hormone Research Reports, May 2013

You might be interested in: cancer, therapeutics, hair care, more »


 

1-20 of about 700 reports for Hormone
The U.S. Market for Rx to OTC Switches, 6th Edition

The U.S. Market for Rx to OTC Switches, 6th Edition

  • $ 3 995
  • Industry report
  • January 2013
  • by Kalorama Information

The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription. This report ...

Australia Systemic Hormonal Preparation, Excluding Sex Hormones And Insulin, Prescription Drug Sales, Audmn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2004 To 2008
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI

Australia Systemic Hormonal Preparation, Excluding Sex Hormones And Insulin, Prescription Drug Sales, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2004 To 2008
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI

Prostate Cancer Drug Pipeline Update 2013

Prostate Cancer Drug Pipeline Update 2013

  • $ 2 249
  • Industry report
  • April 2013
  • by Bioseeker

Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players` sales have been eroded by the launch of various ...

World Drug and Medication: Neuroendocrine Tumors - Pipeline Review, H1 2012

World Drug and Medication: Neuroendocrine Tumors - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Neuroendocrine Tumors, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

Osteoporosis Treatment Drugs  Markets in China

Osteoporosis Treatment Drugs Markets in China

  • $ 2 000
  • Industry report
  • May 2013
  • by Asia Market Information & Development Company

China's demand for osteoporosis treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic ...

Pancreatic Cancer Drug Pipeline Update 2013

Pancreatic Cancer Drug Pipeline Update 2013

  • $ 2 249
  • Industry report
  • April 2013
  • by Bioseeker

There are today 249 companies plus partners developing 290 drugs targeting pancreatic cancer in development. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the ...

BioSante Pharmaceuticals, Inc. (Symbol:BPAX) SWOT Analysis, Strategy, Revenues and Profits

BioSante Pharmaceuticals, Inc. (Symbol:BPAX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Colorectal Cancer Drug Pipeline Update 2013

Colorectal Cancer Drug Pipeline Update 2013

  • $ 2 249
  • Industry report
  • April 2013
  • by Bioseeker

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...

Blood Disease Treatment Drugs Markets in China

Blood Disease Treatment Drugs Markets in China

  • $ 2 000
  • Industry report
  • May 2013
  • by Asia Market Information & Development Company

China's demand for blood treatment disease drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic ...

Anti-Tumor Drugs Markets in China

Anti-Tumor Drugs Markets in China

  • $ 2 000
  • Industry report
  • May 2013
  • by Asia Market Information & Development Company

China's demand for anti-tumor drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, ...

Cancer Vaccines Drug Pipeline Update 2013

Cancer Vaccines Drug Pipeline Update 2013

  • $ 2 249
  • Industry report
  • April 2013
  • by Bioseeker

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has ...

Bioenvision, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioenvision, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2013
  • by Global Data

Summary Bioenvision, Inc. (Bioenvision) is a pharmaceutical company, engaged in acquiring, developing and marketing compounds and technologies used in the treatment of cancer. Bioenvision's primary products ...

Brazil Pharmaceutical Exports - Alkaloids And Its Derivatives, Not Containing Antibiotics Or Hormones, In Dosage, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Canada Pharmaceutical Exports - Alkaloids And Its Derivatives, Not Containing Antibiotics Or Hormones, In Bulk, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Brazil Pharmaceutical Exports - Alkaloids And Its Derivatives, Not Containing Antibiotics Or Hormones, In Bulk, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Canada Pharmaceutical Exports - Alkaloids And Its Derivatives, Not Containing Antibiotics Or Hormones, In Dosage, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Australia Genito-urinary System And Sex Hormone Prescription Drug Sales, Audmn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2004 To 2008
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI

Australia Genito-urinary System And Sex Hormone Prescription Drug Sales, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2004 To 2008
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI

Canada Pharmaceutical Exports - Other Hormones Not Elsewhere Specified, Not Including Antibiotics Or Contraceptives, In Bulk, Us$mn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

» Download Public Reports

About 2 400 reports for Hormone
Hormone Market in The United States

Hormone Market in The United States

  • Industry report
  • January 2012
  • 3 pages

Hormone Business Brief

December 2011

Hormone Market Brief

December 2011

Hormone Sector Brief

December 2011

» Read our Company Profiles

6 Companies for Hormone

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Eli Lilly and Co.

United States

Johnson and Johnson

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.